Article
The translational expression of ABCA2 and ABCA3 is a strong prognostic biomarker for…
OncoTargets and Therapy · 2017 · Aberuyi N, Rahgozar S, Khosravi Dehaghi Z, Moafi A, Masotti A, Paolini A
Key facts
| Title | The translational expression of ABCA2 and ABCA3 is a strong prognostic biomarker for multidrug resistance in pediatric acute lymphoblastic leukemia |
|---|---|
| First author | Aberuyi N, Rahgozar S, Khosravi Dehaghi Z, Moafi A, Masotti A, Paolini A |
| Journal | OncoTargets and Therapy |
| Published | Jul 10, 2017 |
| DOI | 10.2147/OTT.S140488 |
| Devices mentioned | K111034, K120836, K181380, K810863 |
| Product codes mentioned | DBM, MAX, NGT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1